TY - JOUR T1 - Dexmedetomidine withdrawal syndrome and opioid sensitivity JF - BMJ Supportive & Palliative Care JO - BMJ Support Palliat Care DO - 10.1136/bmjspcare-2020-002705 SP - bmjspcare-2020-002705 AU - Lana Ferguson AU - Stacey Hooper Y1 - 2020/12/22 UR - http://spcare.bmj.com/content/early/2021/09/26/bmjspcare-2020-002705.abstract N2 - This case report describes the use of dexmedetomidine for refractory cancer pain management in a patient with significant pelvic disease due to metastatic urothelial cancer. Specifically, the management of increased opioid sensitivity secondary to dexmedetomidine is discussed. Further, the phenomenon of dexmedetomidine withdrawal syndrome and our management of this is addressed. ER -